By Colin Kellaher Immunogen has won U.S. Food and Drug Administration priority review for its application seeking to convert the accelerated approval of its.
By Stephen Nakrosis Vanda Pharmaceuticals said the Food and Drug Administration accepted the filing of the company's new drug application for tradipitant to.
By Denny Jacob Eli Lilly's Jaypirca was approved by the Food and Drug Administration to treat adults with chronic lymphocytic leukemia or small lymphocytic.
By Stephen Nakrosis Astellas Pharma and Seagen said the Food and Drug Administration has accepted for priority review a supplemental biologics license.